Sweden 22 May 2014
Our client, the Swedish pharmaceutical company Orexo, was rewarded with the SwedenBio Award yesterday. The prize is awarded by the Swedish trade association for the life science industry, SwedenBio , and is given to a company that has achieved particular success during the past year.
Groth & Co would like to congratulate Orexo for this award!
Criteria for award
The nominated company must:
During the past year Orexo has succeeded in getting the proprietary product Zubsolv both approved and launched in the United States. Swedish life science companies always need to have a strong international presence and in that area Orexo a true role model. Orexo manages to combine a strong presence and sales organization in the U.S. with a successful R&D in Sweden. Through the company’s leadership Orexo has established itself as growing niche pharmaceutical company that can serve as inspiration for the entire Swedish life science industry.